DK0804465T3 - Nye elastaseinhibitorer - Google Patents

Nye elastaseinhibitorer

Info

Publication number
DK0804465T3
DK0804465T3 DK95918993T DK95918993T DK0804465T3 DK 0804465 T3 DK0804465 T3 DK 0804465T3 DK 95918993 T DK95918993 T DK 95918993T DK 95918993 T DK95918993 T DK 95918993T DK 0804465 T3 DK0804465 T3 DK 0804465T3
Authority
DK
Denmark
Prior art keywords
inhibitors
elastase inhibitors
elastase
compounds
new
Prior art date
Application number
DK95918993T
Other languages
Danish (da)
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Michael R Angelastro
William A Metz Jr
Steven L Gallion
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0804465T3 publication Critical patent/DK0804465T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95918993T 1994-06-02 1995-05-05 Nye elastaseinhibitorer DK0804465T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
PCT/US1995/005618 WO1995033763A1 (fr) 1994-06-02 1995-05-05 Nouveaux inhibitieurs d'elastase

Publications (1)

Publication Number Publication Date
DK0804465T3 true DK0804465T3 (da) 2003-11-24

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918993T DK0804465T3 (da) 1994-06-02 1995-05-05 Nye elastaseinhibitorer

Country Status (20)

Country Link
EP (1) EP0804465B1 (fr)
JP (1) JP3623799B2 (fr)
KR (1) KR100347285B1 (fr)
CN (1) CN1149877A (fr)
AT (1) ATE246708T1 (fr)
AU (1) AU689589B2 (fr)
CA (1) CA2189527C (fr)
DE (1) DE69531459T2 (fr)
DK (1) DK0804465T3 (fr)
ES (1) ES2199992T3 (fr)
FI (1) FI964781L (fr)
HU (1) HU221197B1 (fr)
IL (1) IL113940A (fr)
NO (1) NO965097L (fr)
NZ (1) NZ285565A (fr)
PT (1) PT804465E (fr)
SI (1) SI0804465T1 (fr)
TW (1) TW403762B (fr)
WO (1) WO1995033763A1 (fr)
ZA (1) ZA954430B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
DK0763055T3 (da) * 1994-06-02 2000-05-08 Merrell Pharma Inc Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
HRP20080014T3 (en) 2003-05-21 2008-02-29 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor compounds
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
JP4914355B2 (ja) 2004-07-20 2012-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎インヒビターペプチド類似体
US7951823B2 (en) 2006-05-23 2011-05-31 Irm Llc Compounds and compositions as channel activating protease inhibitors
KR20090108131A (ko) * 2007-02-09 2009-10-14 아이알엠 엘엘씨 채널 활성화 프로테아제 억제제로서의 화합물 및 조성물
WO2021053058A1 (fr) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvélestat destiné à être utilisé dans le traitement du rejet de greffe, du syndrome de bronchiolite oblitérante et de la maladie du greffon contre l'hôte
LT4106757T (lt) 2020-04-16 2023-11-10 Mereo Biopharma 4 Limited Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
JP2024540952A (ja) 2021-10-20 2024-11-06 メレオ バイオファーマ ４ リミテッド 線維化の治療における使用のための好中球エラスターゼ阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0204571B1 (fr) * 1985-06-07 1992-01-22 Ici Americas Inc. Dérivés difluoro choisis
CA2021660A1 (fr) * 1989-07-26 1991-01-27 Philippe Bey Inhibiteurs de la peptidose
CA2098702A1 (fr) * 1990-12-28 1992-06-29 James C. Powers Cetoamides, cetoacides et cetoesters de nature peptidique
AU655831B2 (en) * 1991-08-22 1995-01-12 Merrell Pharmaceuticals Inc. Novel orally-active elastase inhibitors

Also Published As

Publication number Publication date
KR100347285B1 (ko) 2003-01-15
NO965097D0 (no) 1996-11-29
JP3623799B2 (ja) 2005-02-23
FI964781A7 (fi) 1997-01-29
TW403762B (en) 2000-09-01
AU689589B2 (en) 1998-04-02
SI0804465T1 (en) 2003-12-31
PT804465E (pt) 2003-12-31
ES2199992T3 (es) 2004-03-01
ZA954430B (en) 1996-02-13
HUT76926A (hu) 1998-01-28
CN1149877A (zh) 1997-05-14
IL113940A0 (en) 1995-08-31
WO1995033763A1 (fr) 1995-12-14
MX9606030A (es) 1998-05-31
EP0804465A1 (fr) 1997-11-05
NO965097L (no) 1997-01-31
HU9603312D0 (en) 1997-01-28
FI964781L (fi) 1997-01-29
CA2189527C (fr) 2000-12-19
AU2470995A (en) 1996-01-04
DE69531459T2 (de) 2004-06-24
NZ285565A (en) 1998-08-26
FI964781A0 (fi) 1996-11-29
DE69531459D1 (de) 2003-09-11
JPH10500992A (ja) 1998-01-27
HU221197B1 (en) 2002-08-28
CA2189527A1 (fr) 1995-12-14
EP0804465B1 (fr) 2003-08-06
IL113940A (en) 1999-12-31
ATE246708T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
SE9504661D0 (sv) New compounds
ATE427300T1 (de) Heterocyclisch substituierte amide als calpainhemmer
NO965097D0 (no) Nye elastaseinhibitorer
ES2192839T3 (es) Timosina beta 4 oxidada.
NO934218D0 (no) Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
TR199801614T2 (xx) Peptit t�revleri
ECSP055844A (es) Nuevos compuestos triciclicos
DE69629023D1 (de) Piperazino-derivative als neurokininantagonisten
ES2142490T3 (es) Ciclopeptolidos.
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
ATE328898T1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
SE9504662D0 (sv) New compounds
BRPI0415355A (pt) triarilimidazóis
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten